Refreshing results…
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts
UploadA burned-out CD8+ T-cell subset expands in the tumor microenvironment and curbs cancer immunotherapy
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.